Sanofi's dengue vaccine approved in Singapore and 10 other countries
[PARIS] Sanofi Pasteur, Sanofi's vaccines unit, said on Tuesday that its dengue vaccine, Dengvaxia, had received market approval in eleven countries.
To date the vaccine has been approved in Mexico, the Philippines, Brazil, El Salvador, Costa Rica, Paraguay, Guatemala, Peru, Indonesia, Thailand and Singapore, the statement said.
Dengue fever is a mosquito-borne disease caused by four virus serotypes (1 to 4) as categorised by the World Health Organisation.
Overall, the disease is seen as a threat to about half of the world's population. Some 400 million people are believed to be infected annually.
REUTERS
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Economy & Policy
Daily Debrief: What Happened Today (Apr 26)
Singapore must prepare for slower growth at higher costs: MAS
Outgoing Singapore, Indonesia leaders to hold their final retreat in Bogor on Apr 29
Singapore factory output reverses into negative territory in March, down 9.2%
Singapore’s growth should strengthen to ‘around potential rate’, output gap to close by end-2024: MAS
Gan Kim Yong visits US and Canada; to mark 20th anniversary of US-Singapore FTA